COMP <GO>
BC vs TMO // ENTERPRISE SCALE & MARKET CAP
Brunswick Corporation (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: BC 4
— TMO 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TMO
LAST: $75.34 (+1.32%) • MKT CAP: $4.82B
market-cap
$4.82B
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
market-cap
$262.22B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BC VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BC | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.80% | 41.00% | -16.20 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -1.00% | 9.30% | -10.30 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.22% | 2.40% | +5.82 | BC | /fcf-yield <GO> |
| Operating Margin | -0.80% | 17.40% | -18.20 | TMO | /operating-margins <GO> |
| Net Profit Margin | -2.60% | 15.10% | -17.70 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 2.40% | 3.90% | -1.50 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.34% | 0.24% | +2.10 | BC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.15 | 4.50 | -1.35 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.70% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 70.2 | 59.1 | +11.06 | BC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.94 | -0.01 | TMO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.0x | 36.3x | -1.30 | BC | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $4.82B | $262.22B | -$257.40B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BC REV | TMO REV | BC GROSS % | TMO GROSS % | BC FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.36B | $44.56B | 24.8% | 44.0% | $396.3M | $6.29B |
| FY 2024 | $5.24B | $42.88B | 25.8% | 44.0% | $264.0M | $7.27B |
| FY 2023 | $6.40B | $42.86B | 44.0% | 44.0% | $445.5M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BC // BETA 0.93
TMO // BETA 0.94